Literature DB >> 12735496

Mixed discrete and continuous Cox regression model.

Ross L Prentice1, John D Kalbfleisch.   

Abstract

The Cox (1972) regression model is extended to include discrete and mixed continuous/discrete failure time data by retaining the multiplicative hazard rate form of the absolutely continuous model. Application of martingale arguments to the regression parameter estimating function show the Breslow(1974) estimator to be consistent and asymptotically Gaussian under this model. A computationally convenient estimator of the variance of the score function can be developed, again using martingale arguments. This estimator reduces to the usual hypergeometric form in the special case of testing equality of several survival curves, and it leads more generally to a convenient consistent variance estimator for the regression parameter. A small simulation study is carried out to study the regression parameter estimator and its variance estimator under the discrete Cox model special case and an application to a bladder cancer recurrence dataset is provided.

Entities:  

Mesh:

Year:  2003        PMID: 12735496     DOI: 10.1023/a:1022935019768

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  1 in total

1.  Covariance analysis of censored survival data.

Authors:  N Breslow
Journal:  Biometrics       Date:  1974-03       Impact factor: 2.571

  1 in total
  13 in total

1.  Empirical receiver operating characteristic curve for two-sample comparison with cure fractions.

Authors:  Xiaobing Zhao; Xian Zhou
Journal:  Lifetime Data Anal       Date:  2010-03-11       Impact factor: 1.588

2.  Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Authors:  Sanne Noort; Martin Zimmermann; Dirk Reinhardt; Wendy Cuccuini; Martina Pigazzi; Jenny Smith; Rhonda E Ries; Todd A Alonzo; Betsy Hirsch; Daisuke Tomizawa; Franco Locatelli; Tanja A Gruber; Susana Raimondi; Edwin Sonneveld; Daniel K Cheuk; Michael Dworzak; Jan Stary; Jonas Abrahamsson; Nira Arad-Cohen; Malgorzata Czogala; Barbara De Moerloose; Henrik Hasle; Soheil Meshinchi; Marry van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

3.  Additive hazards regression and partial likelihood estimation for ecological monitoring data across space.

Authors:  Feng-Chang Lin; Jun Zhu
Journal:  Stat Interface       Date:  2012       Impact factor: 0.582

4.  Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.

Authors:  Long Fu Xi; Mark Schiffman; Yang Ke; James P Hughes; Denise A Galloway; Zhonghu He; Ayaka Hulbert; Rachel L Winer; Laura A Koutsky; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2017-01-24       Impact factor: 7.396

5.  Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.

Authors:  Hee-Koung Joeng; Ming-Hui Chen; Sangwook Kang
Journal:  Lifetime Data Anal       Date:  2015-03-15       Impact factor: 1.588

6.  Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.

Authors:  Theodore H Welling; Kevin Eddinger; Kristen Carrier; Danting Zhu; Tyler Kleaveland; Derek E Moore; Douglas E Schaubel; Peter L Abt
Journal:  Liver Transpl       Date:  2018-09       Impact factor: 5.799

7.  Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Ayaka Hulbert; Zhenping Shen; Denise A Galloway; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2016-05-14       Impact factor: 7.396

8.  Analyzing wearable device data using marked point processes.

Authors:  Yuchen Yang; Mei-Cheng Wang
Journal:  Biometrics       Date:  2020-05-06       Impact factor: 2.571

9.  Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

Authors:  Marysia Hengeveld; Stefan Suciu; Matthias Karrasch; Giorgina Specchia; Jean-Pierre Marie; Petra Muus; Maria C Petti; Bruno Rotoli; Sergio Amadori; Guiseppe Fioritoni; Pietro Leoni; Enrica Morra; Joseph Thaler; Luigi Resegotti; Paola Fazi; Marco Vignetti; Franco Mandelli; Robert Zittoun; Theo de Witte
Journal:  Ann Hematol       Date:  2012-03-31       Impact factor: 3.673

10.  Impact of changes in metabolic control on progression to photocoagulation for clinically significant macular oedema: a 20 year study of type 1 diabetes.

Authors:  B Sander; M Larsen; E W Andersen; H Lund-Andersen
Journal:  Diabetologia       Date:  2013-08-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.